Optimizing Market Access in Specialty Launches

Looking forward to this session? Share it!

As the US healthcare landscape continues to evolve at a rapid pace, it is imperative for drug and therapeutic manufacturers to consider the role of market access earlier in the development pipeline. This discussion will highlight the critical role that access plays in the specialty space, and how we can no longer assume that high unmet need alone will be sufficient to garner access for a novel therapeutic. We will cover:

• A brief landscape of the specialty pharma space, including recent payer decisions
• Several case studies as to how early planning secured optimal access
• An overview of launch planning and where access planning is key to success